Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, CXCR4 | 1 | 2021 | 737 | 0.620 |
Why?
|
Neoplastic Stem Cells | 3 | 2021 | 1390 | 0.500 |
Why?
|
Autocrine Communication | 1 | 2013 | 188 | 0.490 |
Why?
|
Aquaporins | 1 | 2013 | 175 | 0.480 |
Why?
|
Esophageal Neoplasms | 3 | 2016 | 1525 | 0.460 |
Why?
|
Multiple Myeloma | 4 | 2022 | 4844 | 0.450 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 499 | 0.400 |
Why?
|
Epithelium | 1 | 2014 | 1774 | 0.390 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5265 | 0.360 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 3053 | 0.360 |
Why?
|
Cell Division | 1 | 2016 | 4906 | 0.350 |
Why?
|
Ion Channels | 1 | 2013 | 1103 | 0.350 |
Why?
|
Transcription, Genetic | 1 | 2021 | 8130 | 0.320 |
Why?
|
Immunotherapy | 1 | 2021 | 3793 | 0.310 |
Why?
|
Cell Lineage | 4 | 2021 | 2676 | 0.280 |
Why?
|
Stem Cells | 2 | 2014 | 3612 | 0.250 |
Why?
|
Cell Differentiation | 2 | 2016 | 11833 | 0.220 |
Why?
|
Cell Proliferation | 2 | 2016 | 10990 | 0.210 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13898 | 0.200 |
Why?
|
Galectins | 1 | 2021 | 238 | 0.180 |
Why?
|
Immune Evasion | 1 | 2021 | 337 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 371 | 0.170 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 665 | 0.170 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4648 | 0.160 |
Why?
|
Mutation | 5 | 2021 | 28848 | 0.150 |
Why?
|
Clone Cells | 2 | 2014 | 1776 | 0.130 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1721 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8895 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 2013 | 270 | 0.120 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2048 | 0.110 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2884 | 0.090 |
Why?
|
Esophagus | 1 | 2014 | 1028 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 17251 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2016 | 10094 | 0.080 |
Why?
|
Melanoma | 1 | 2021 | 5505 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3337 | 0.050 |
Why?
|
Animals | 5 | 2016 | 170849 | 0.050 |
Why?
|
Humans | 9 | 2022 | 686663 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59331 | 0.040 |
Why?
|
Treatment Failure | 1 | 2022 | 2697 | 0.040 |
Why?
|
Paris | 1 | 2014 | 41 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6835 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3881 | 0.030 |
Why?
|
Aged | 2 | 2021 | 162271 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 1885 | 0.030 |
Why?
|
Female | 3 | 2021 | 375459 | 0.030 |
Why?
|
Middle Aged | 2 | 2021 | 216468 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2014 | 754 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39737 | 0.020 |
Why?
|
Male | 2 | 2021 | 352465 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 5044 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5252 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 8610 | 0.020 |
Why?
|
Prognosis | 1 | 2021 | 28923 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21684 | 0.010 |
Why?
|
Infant | 1 | 2021 | 33918 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 6009 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41159 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56052 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 11910 | 0.010 |
Why?
|
Child | 1 | 2021 | 71361 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 84957 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 42271 | 0.010 |
Why?
|
Mice | 1 | 2014 | 80803 | 0.010 |
Why?
|
Adult | 1 | 2021 | 211400 | 0.000 |
Why?
|
Concepts
(65)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_